Immunophilin ligands as a novel treatment of neurological disorders

T Herdegan1, G Fischer, B G Bold

  • 1Institute of Pharmacology, University of Kiel, Germany. t.herdegan@pharmakologie.uni-kiel.de

Abstract

No abstract available in PubMed .